Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $99.89 USD
Change Today -0.29 / -0.29%
Volume 345.6K
RNR On Other Exchanges
New York
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin J. O'Donnell

Chief Executive Officer, President, Director, Chairman of Transaction Committee and Chairman of Offerings Committee, RenaissanceRe Holdings Ltd.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Kevin J. O'Donnell has been Chief Executive Officer and President at RenaissanceRe Holdings Ltd. since July 1, 2013 and November 13, 2012 respectively. Mr. O'Donnell serves as the President of Sacred Heart-St Mary's Hospital Inc. He served as the Chief Executive Officer at Renaissance Reinsurance Ltd. He served as Group Chief Underwriting Officer of RenaissanceRe Holdings Ltd until July 2014. He served as the Senior Vice President of Property Catastrophe Reinsurance ...

Read Full Background

Corporate Headquarters*

Renaissance House
Pembroke, -- HM 19


Phone: 441-295-4513
Fax: --

Board Members Memberships*

Chief Executive Officer, President, Director, Chairman of Transaction Committee and Chairman of Offerings Committee


New York University - Leonard N. Stern School of Business
Hamilton College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$887,500

Stock Options*

Restricted Stock Awards$4,316,338
All Other Compensation$616,320
Exercisable Options453,767
Exercisable Options Value$15,997,965
Total Value of Options$15,997,965
Total Number of Options453,767

Total Compensation*

Total Annual Cash Compensation$3,916,950
Total Short Term Compensation$887,500
Other Long Term Compensation$4,932,658
Total Calculated Compensation$8,233,288
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RNR:US $99.89 USD -0.29


Bronislaw Edmund Masojada Chief Executive Officer, Executive Director, Member of Investment Committee and Director of Hiscox Syndicates Limited
Hiscox, Ltd.
1.6M GBP
Charles E. L. Philipps ACAChief Executive Officer, Director, Chairman of Group Management Committee, Chairman of Underwriting Review Board Committee, Chairman of Group Executive Risk Committee, Member of Nomination Committee and Member of Investment Management Executive Committee
Amlin plc
1.5M GBP
John R. Charman Chairman, Chief Executive Officer, Member of Risk Committee and Member of Finance Committee
Endurance Specialty Holdings Ltd.
Scott A. Carmilani Chairman, Chief Executive Officer, President and Chairperson of Executive Committee
Allied World Assurance Company Holdings, AG
Edward Joseph Noonan Chairman, Chief Executive Officer, Member of Executive Committee, Member of Finance Committee, Member of Risk Committee, Chairman of the Validus Group and Chief Executive Officer of the Validus Group
Validus Holdings, Ltd.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RENAISSANCERE HOLDINGS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at